Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:ganirelix_acetate
|
| gptkbp:approvalYear |
1999
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
H01CC02
|
| gptkbp:brand |
Antagon
|
| gptkbp:contraindication |
pregnancy
hypersensitivity to ganirelix |
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ganirelix Acetate Injection
|
| gptkbp:indication |
prevention of premature luteinizing hormone surges
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
GnRH antagonist
|
| gptkbp:pregnancyCategory |
gptkb:X_(US)
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
nausea
abdominal pain headache injection site reaction |
| gptkbp:usedIn |
assisted reproductive technology
|
| gptkbp:bfsParent |
gptkb:Organon_(2021_spin-off)
gptkb:Organon_&_Co._(2021) |
| gptkbp:bfsLayer |
6
|